Astellas Pharma Inc. ALPMF
Set alert
15.00 USD -2.40 -13.79%
At close · Oct 30
15.00 Day range 15.00
10.00 52-week range 17.85
- YTD
- +13.90%
- 1 year
- +49.55%
- Open
- 15.00
- Prev close
- 17.40
- Mkt cap
- 26.90B
- Vol
- 341
- Avg vol
- 5.76K
- EPS
- 1.32
- P/E
- 11.36
More statistics
- Low
- 15.00
- High
- 15.00
- Earnings
- Nov 4, 2026
2Y chart
Events in this range
- Mar 28, 2025Dividend: 0.2468
- Mar 31, 2025Dividend: 0.2468
- Jul 30, 2025Earnings: 0.2652; estimate 0.1379; surprise 92.31%
- Sep 29, 2025Dividend: 0.2713
- Sep 30, 2025Dividend: 0.2636
- Oct 30, 2025Earnings: 0.2989; estimate 0.2015; surprise 48.34%
- Feb 4, 2026Earnings: 0.3576; estimate 0.2931; surprise 22.01%
- Mar 31, 2026Dividend: 0.2452
- Apr 27, 2026Earnings: 0.153; estimate 0.1926; surprise -20.56%
- Aug 5, 2026Earnings: 0.4867; estimate 0.3327; surprise 46.29%
- Sep 29, 2026Dividend: 0.254
- Sep 30, 2026Dividend: 0.2544
Signals (158)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Nov 2, 2026 | 1 day ago |
| SMA: Bullish | Nov 2, 2026 | 1 day ago |
| SMA: Bearish | Oct 30, 2026 | 4 days ago |
| SMA: Bearish | Oct 30, 2026 | 4 days ago |
| SMA: Bullish | Oct 19, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 19, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 19, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 13, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 13, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 7, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 7, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
| MACD: Sell Signal | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Sep 30, 2026 | 1 month ago |
| SMA: Bearish | Sep 30, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 28, 2026 | 1 month ago |
| SMA: Bullish | Sep 21, 2026 | 1 month ago |
Newest 20 of 158.
Next earnings
Nov 4, 2026
Expected Nov 4, 2026. Consensus EPS estimate 0.3937.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 4, 2026 | Sep 30, 2026 | 0.3937 | — | — | — |
| Aug 5, 2026 | Jun 30, 2026 | 0.3327 | 0.4867 | +0.15 | +46.29% |
| Apr 27, 2026 | Mar 31, 2026 | 0.1926 | 0.153 | -0.04 | -20.56% |
| Feb 4, 2026 | Dec 31, 2025 | 0.2931 | 0.3576 | +0.06 | +22.01% |
| Oct 30, 2025 | Sep 30, 2025 | 0.2015 | 0.2989 | +0.10 | +48.34% |
| Jul 30, 2025 | Jun 30, 2025 | 0.1379 | 0.2652 | +0.13 | +92.31% |
News
- Merck Advances European Regulatory Approval For Keytruda Combination In Bladder Cancer
- Impax International Sustainable Economy Fund Q2 2026 Contributors And Detractors
- Astellas Pharma Inc. (ALPMY) Q4 2026 Earnings Call Transcript
- Astellas Pharma Inc. (ALPMY) Discusses R&D Strategy and Focus Areas in Innovative Healthcare Transcript
- Vir Biotechnology: Up On Prostate Data And Astellas Deal - I'm (Long-Term) Bullish
- These Analysts Boost Their Forecasts On Vir Biotechnology
- What's Going On With Kyntra Bio Stock Tuesday?
- Vir Biotechnology Stock Hits 52-Week High Tuesday - Here's Why
- Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer
- India's Lupin clears patent hurdle with Astellas Pharma, keeps Mirabegron sales in US
Your note
Sign in to keep a note on ALPMF — it syncs with the Stock Master app.